Grace Therapeutics GRCE
NASDAQ GRCE
$2.26 +0.12 (+5.61%)
At close: Sep 10, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Prepaid Assets (2019 - 2026)

Grace Therapeutics' (GRCE) quarterly Prepaid Assets came in at $557000.0 in Q2 2026, up 11.4% year-over-year from $500000.0 in Q2 2025, and up 45.43% quarter-over-quarter from $383000.0 in Q1 2026.

Analysis

Grace Therapeutics (GRCE) Prepaid Assets (2019 - 2026) Analysis & Trends

Grace Therapeutics has disclosed Prepaid Assets across 8 years of filings, most recently posting $557000.0 for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 11.4% year-over-year to $557000.0; the TTM figure through Jun 2026 stood at $557000.0 (up 11.4% YoY), while the FY2026 annual figure was $383000.0, down 15.45% from the prior year.
  • Prepaid Assets came in at $557000.0 for Q2 2026 at Grace Therapeutics, up from $383000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.5 million in Q2 2022 to a low of $283000.0 in Q1 2024.
  • Average Prepaid Assets over 5 years is $723777.8, with a median of $590500.0 recorded in 2023.
  • Year-over-year, Prepaid Assets soared 109.91% in 2022 and slumped 54.31% in 2024.
  • Over 5 years, Prepaid Assets stood at $1.0 million in 2022, then dropped by 22.17% to $811000.0 in 2023, then declined by 28.11% to $583000.0 in 2024, then slipped by 10.98% to $519000.0 in 2025, then gained by 7.32% to $557000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $557000.0 in Q2 2026, $383000.0 in Q1 2026, and $519000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn
10 Grace Therapeutics 39.38 Mn 39.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 557,000.00
Mar 31, 2026 383,000.00
Dec 31, 2025 519,000.00
Sep 30, 2025 416,000.00
Jun 30, 2025 500,000.00
Mar 31, 2025 453,000.00
Dec 31, 2024 583,000.00
Sep 30, 2024 477,000.00
Jun 30, 2024 622,000.00
Mar 31, 2024 283,000.00
Dec 31, 2023 811,000.00
Sep 30, 2023 1.04 Mn
Jun 30, 2023 1.13 Mn
Mar 31, 2023 598,000.00
Dec 31, 2022 1.04 Mn
Sep 30, 2022 1.35 Mn
Jun 30, 2022 1.54 Mn
Mar 31, 2022 720,000.00
Dec 31, 2021 1.85 Mn
Sep 30, 2021 2.18 Mn